Longlife Hericium Bio 60 Capsule
LONGLIFE
HERICIUM BIO 500 MG
Descrizione
Integratore alimentare a base di di Hericium titolato al 50% in polisaccaridi e
al 20% in beta(1,3-1,6)-D-glucani, da agricoltura biologica. Adatto a vegani,
DNA certificato, doping free.
Ingredienti
Hericium erinaceus sporoforo*; capsula di origine vegetale in
idrossipropilmetilcellulosa.
*Ingrediente biologico.
Senza glutine.
Caratteristiche nutrizionali
Valori medi per 2 capsuleHericium erinaceus (Bull.) Pers* sporoforo
polvere titolata
50% polisaccaridi totali
20% beta(1,3-1,6)-D-glucani1.000 mg
500 mg
200 mg
Capsula di origine vegetale in idrossipropilmetilcellulosa
Modalità d'uso
Assumere 1 capsula due volte al giorno durante i pasti.
Avvertenze
Non eccedere la dose giornaliera raccomandata.
Tenere fuori dalla portata dei bambini al di sotto dei 3 anni di età.
Gli integratori non vanno intesi come sostituti di una dieta variata e vanno
utilizzati seguendo uno stile di vita sano ed equilibrato.
Conservazione
Conservare in luogo fresco ed asciutto.
Validità a confezionamento integro: 36 mesi.
Formato
Flacone contenente 60 capsule da 0,600 g.
Peso netto: 36 g.
Cod. 0419
Bibliografia
-Phan CW et al., Hericium erinaceus (Bull.: Fr) Pers. cultivated under tropical
conditions: isolation of hericenones and demonstration of NGF-mediated neurite
outgrowth in PC12 cells via MEK/ERK and PI3K-Akt signaling pathways, Food Funct.
2014 Dec;5(12):3160-9.
-Lee KF et al., Protective effects of Hericium erinaceus mycelium and its
isolated erinacine A against ischemia-injury- induced neuronal cell death via
the inhibition of iNOS/p38 MAPK and nitrotyrosine, Int J Mol Sci. 2014 Aug 27;15
(9):15073-89.
-Jiang S et al., Medicinal properties of Hericium erinaceus and its potential to
formulate novel mushroom-based pharmaceuticals, Appl Microbiol Biotechnol. 2014
Sep;98(18):7661-70.
-Zhu Y et al., Preparation, characterization, and anti-Helicobacter pylori
activity of Bi3+-Hericium erinaceus polysaccharide complex, Carbohydr Polym.
2014 Sep 22;110:231.
-Xinyi Zan et al., Hericium erinaceus polysaccharide-protein HEG-5 inhibits
SGC-7901 cell growth via cell cycle arrest and apoptosis, International Journal
of Biological Macromolecules, 2015, 76, 242-253. Liu Z, et al., Systemic
Screening of Strains of the Lion's Mane Medicinal Mushroom Hericium
erinaceus(Higher Basidiomycetes) and Its Protective Effects on A-Triggered.
-Neurotoxicity in PC12 Cells, Int J Med Mushrooms. 2015;17(3):219-29.
-Zhang Yi et al., Protective Effect of Ethanol Extracts of Hericium erinaceus on
Alloxan- Induced Diabetic Neuropathic Pain in Rats, Evidence-Based Complementary
and Alternative Medicine Volume 2015, Article ID 595480, 5 pages.
-Zan X et al., Hericium erinaceus polysaccharide-protein HEG-5 inhibits SGC-7901
cell growth via cell cycle arrest and apoptosis, Int J Biol Macromol. 2015
May;76:242-53.
-Liu J et al., Anti-fatigue activities of polysaccharides extracted from
Hericium erinaceus., Exp Ther Med. 2015 Feb;9 (2):483-487.
-Wang K, et al., Erinacerins C-L, isoindolin-1-ones with-glucosidase inhibitory
activity from cultures of the medicinal mushroom Hericium erinaceus, J Nat Prod.
2015 Jan 23;78(1):146-54.
-Hou Y et al., Composition and antioxidant activity of water-soluble
oligosaccharides from Hericium erinaceus, Mol Med Rep. 2015 May;11(5):3794-9.
-Kobayashi H, et al., Effect of the replacement of aspartic acid/glutamic acid
residues with asparagine/glutamine residues in RNase He1 from Hericium erinaceus
on inhibition of human leukemia cell line proliferation., Biosci Biotechnol
Biochem. 2015;79(2):211-7.
